In addition, practical tips relating to technology decisions will be presented.
Four case studies of recent HTA decisions will be presented as part of the focus groups: Ipilimumab for advanced stage melanoma injection of Botulinum toxin for chronic migraine magnetic resonance imaging (MRI) for diagnosis of Crohn's disease hypobaric oxygen therapy (HBOT) for chronic skin ulcers.
A general model for knowledge-based decision making will be presented, and the special cases as applicable to some common concepts of approximation will be studied.
As alternative trial designs become more common in RCTs, systematic review investigators, health technology assessment specialists, and policy decision makers will be presented with unique challenges for incorporating these trials in NMAs and ITCs.
Clinicians involved in thrombolysis decision-making will be presented with hypothetical patient vignettes which vary in terms of their characteristics (patient factors, eg, age) and the magnitude of these characteristics (levels, eg, patient age 75 or 85 years) and asked to state whether they would offer thrombolysis.
Issues like topic and conference arrangement are likely to influence the decision whether a abstract will be presented as poster or oral.
The decision context and hierarchical model will be presented to a panel of experts on at least two occasions.
The decisions made by the Steering Committee will be presented and justified in the feedback report between the Delphi rounds.
Many industries, from airlines to pharmaceuticals to small retailers, are fighting for a limited supply of hard currency in Venezuela, which means that, so long as the current climate prevails, the country will be presented with decisions about whom to pay.
Decision making regarding endoscopic versus open reconstruction will be presented.
A web-based model to decision model for analysis of structured database will be presented.
